… of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. We aimed
to synthesize seroprevalence data to better estimate the level and distribution of SARS-CoV-2 …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has surprised the world
with its range of disease manifestations, from asymptomatic infection to critical illness leading …

… In a US nationwide survey of SARS-CoV-2 seroprevalence, we tested more than 177 000
residual specimens submitted for non–SARS-CoV-2 testing during 4 periods from July to …

… that SARS-CoV-2 seroprevalence varied markedly among geographic regions, as might
be expected early in a pandemic. Longitudinal surveys to continually monitor seroprevalence …

… and San Francisco 1% seroprevalence to the COVID-19 spike protein. That there is no
detectable cross reactivity to other COVID viruses means some seroprevalence is under detected. …

… seroprevalence is changing over time, overlay diagnostic testing data alongside seroprevalence
estimates, and show seroprevalence … SeroTracker throughout the COVID-19 outbreak to …

… We aimed to identify all studies that reported seroprevalence estimates for SARS-CoV-2 …
to these seroprevalence estimate with the cumulative incidence of confirmed COVID-19 cases, …

… seroprevalence of SARS-CoV-2 … seroprevalence of SARS-CoV-2 antibodies among HCWs,
and the secondary objective was to identify the factors associated with this seroprevalence. …

… We tested each participant for anti-SARS-CoV-2-IgG antibodies using a commercially
available ELISA. We estimated seroprevalence using a Bayesian logistic regression model taking …

… The primary focus was the seroprevalence of SARS-CoV-2 in the ‘general population’—which
we defined as randomly selected people of different age groups, occupations, educational …